Can a virtual health educator get more native americans screened for colon cancer?
NCT ID NCT07254910
First seen Jun 25, 2026 · Last updated Jul 31, 2026 · Updated 3 times
Summary
This study tests two ways to encourage colorectal cancer screening among American Indians in Oklahoma. Participants will either watch a video of a real community health educator or interact with a virtual health educator. The goal is to see which method reaches more people and helps them order a home screening kit. 150 adults aged 45-75 who are up to date on screening can join.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Narrative testimonial video and virtual health educator interaction
- What this could lead to
- If successful, this approach could increase colorectal cancer screening rates in American Indian communities, potentially catching cancer earlier and saving lives.
- What could go wrong
- This is a small feasibility study (150 people) testing reach and engagement, not cancer outcomes. The intervention may not change screening behavior significantly.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 150 people
The number the study aims to enrol. It can still change while the study runs.
- Expected to start
-
Aug 2026
An estimate. Start dates often move.
- Expected to finish
-
Sep 2026
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
45 to 75 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Age 45-75 Live within IHS Clinton Service Unit catchment area Fluent in English and read at or above 6th grade level Self report as American Indian or have CDIB Exclusion Criteria: * Self report up to date with CRC screening FIT within 1 year
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CRC (colorectal cancer) are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
TSET Health Promotion Research Center
RECRUITINGOklahoma City, Oklahoma, 73104, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new drug wipe out hidden cancer DNA and stop colorectal cancer from returning?
- Can protein patterns in stored tumors point to new treatment targets?
- Can a new drug combo shrink advanced colorectal tumors?
- Mailed stool tests could boost colon cancer screening
- Can a four-pronged attack shrink liver tumors enough for surgery?
- Can a Two-Pronged antibody boost chemo against Hard-to-Treat colorectal cancer?